Clinical Trial Update: Savella in Treatment for Provoked Vestibulodynia [Phase 3]

View source ↗

Summary

Milnacipran (Savella) was studied in a Phase 3 trial for provoked vestibulodynia; the study has completed and results have been posted. The conditions include v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vestibulodynia
• Vulvodynia

Drugs mentioned

• SAVELLA (milnacipran hydrochloride)

Snippet

Sponsor: University of Tennessee | Conditions: Vestibulodynia, Vulvodynia | Phase 3 | Status: COMPLETED | Results posted: 2014-04-02